SEC Filings Investor Relations MENUMENUAbout Acer ManagementBoard of DirectorsKey Strategic ConsultantsScientific Advisory BoardCareers Pipeline ACER-001 for UCDACER-001 for MSUDEDSIVO™ for vEDSOsanetant for iVMSEmetine for Infectious Diseases Patients & Physicians Patient AdvocacyPublicationsMedical Information RequestUrea Cycle Disorders (UCDs)Maple Syrup Urine Disease (MSUD)Infectious DiseasesVascular Ehlers-Danlos Syndrome (vEDS)Induced Vasomotor Symptoms (iVMS)Expanded Access Investor Relations Press ReleasesEvents & PresentationsSEC FilingsAnalyst CoverageStock InformationCorporate GovernanceInvestor FAQs Contact Us Year 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Filing Type Current report filing Quarterly Report Annual Report Proxy Filings >All Date Filing Type Report URL Filing Downloads 2021-06-17 8-K Download Report 2021-06-17 8-K Download Report 2021-06-10 8-K Download Report 2021-05-25 8-K Download Report 2021-05-24 8-K Download Report 2021-05-17 10-Q Download Report 2021-05-17 8-K Download Report 2021-04-16 DEF 14A Download Report 2021-04-02 8-K Download Report 2021-03-25 8-K Download Report 2021-03-22 8-K Download Report 2021-03-15 EFFECT Download Report 2021-03-12 424B3 Download Report 2021-03-03 S-1 Download Report 2021-03-03 424B2 Download Report 2021-03-01 10-K Download Report 2021-03-01 8-K Download Report 2021-03-01 S-8 Download Report 2021-02-12 SC 13G/A Download Report 2021-02-11 8-K Download Report 2021-02-05 3 Download Report 2021-02-05 4 Download Report
